These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31861875)

  • 21. PDEδ Binding to Ras Isoforms Provides a Route to Proper Membrane Localization.
    Muratcioglu S; Jang H; Gursoy A; Keskin O; Nussinov R
    J Phys Chem B; 2017 Jun; 121(24):5917-5927. PubMed ID: 28540724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphorylation Weakens but Does Not Inhibit Membrane Binding and Clustering of K-Ras4B.
    Zhang SY; Sperlich B; Li FY; Al-Ayoubi S; Chen HX; Zhao YF; Li YM; Weise K; Winter R; Chen YX
    ACS Chem Biol; 2017 Jun; 12(6):1703-1710. PubMed ID: 28448716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The basis for K-Ras4B binding specificity to protein farnesyltransferase revealed by 2 A resolution ternary complex structures.
    Long SB; Casey PJ; Beese LS
    Structure; 2000 Feb; 8(2):209-22. PubMed ID: 10673434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Carcinogenesis and its mechanism of mutant-type[12Asp]K-ras4B gene].
    Gui LM; Wei LH; Zhang YM; Wang JL; Wang Y; Chen Y; Ma DL
    Ai Zheng; 2002 Jan; 21(1):33-8. PubMed ID: 12500394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid-binding characteristics of the polybasic carboxy-terminal sequence of K-ras4B.
    Leventis R; Silvius JR
    Biochemistry; 1998 May; 37(20):7640-8. PubMed ID: 9585579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computational Design of Myristoylated Cell-Penetrating Peptides Targeting Oncogenic K-Ras.G12D at the Effector-Binding Membrane Interface.
    Li Z; Buck M
    J Chem Inf Model; 2020 Jan; 60(1):306-315. PubMed ID: 31855604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liquid droplets of protein LAF1 provide a vehicle to regulate storage of the signaling protein K-Ras4B and its transport to the lipid membrane.
    Li L; Herzog M; Möbitz S; Winter R
    Phys Chem Chem Phys; 2021 Mar; 23(9):5370-5375. PubMed ID: 33645620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure and function of the C-terminal hypervariable region of K-Ras4B in plasma membrane targetting and transformation.
    Welman A; Burger MM; Hagmann J
    Oncogene; 2000 Sep; 19(40):4582-91. PubMed ID: 11030147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A "Tug of War" Maintains a Dynamic Protein-Membrane Complex: Molecular Dynamics Simulations of C-Raf RBD-CRD Bound to K-Ras4B at an Anionic Membrane.
    Li ZL; Prakash P; Buck M
    ACS Cent Sci; 2018 Feb; 4(2):298-305. PubMed ID: 29532030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probing Colocalization of N-Ras and K-Ras4B Lipoproteins in Model Biomembranes.
    Li L; Dwivedi M; Patra S; Erwin N; Möbitz S; Winter R
    Chembiochem; 2019 May; 20(9):1190-1195. PubMed ID: 30604476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alternative splicing of the K-ras gene in mouse tissues and cell lines.
    Wang Y; You M; Wang Y
    Exp Lung Res; 2001; 27(3):255-67. PubMed ID: 11293328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autopromotion of K-Ras4B Feedback Activation Through an SOS-Mediated Long-Range Allosteric Effect.
    He X; Du K; Wang Y; Fan J; Li M; Ni D; Lu S; Bian X; Liu Y
    Front Mol Biosci; 2022; 9():860962. PubMed ID: 35463958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines.
    Lerner EC; Zhang TT; Knowles DB; Qian Y; Hamilton AD; Sebti SM
    Oncogene; 1997 Sep; 15(11):1283-8. PubMed ID: 9315095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. X-ray structure of a protease-resistant mutant form of human galectin-8 with two carbohydrate recognition domains.
    Yoshida H; Yamashita S; Teraoka M; Itoh A; Nakakita S; Nishi N; Kamitori S
    FEBS J; 2012 Oct; 279(20):3937-51. PubMed ID: 22913484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. K-Ras4B/calmodulin/PI3Kα: A promising new adenocarcinoma-specific drug target?
    Nussinov R; Muratcioglu S; Tsai CJ; Jang H; Gursoy A; Keskin O
    Expert Opin Ther Targets; 2016 Jul; 20(7):831-42. PubMed ID: 26873344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression, purification, and characterization of soluble K-Ras4B for structural analysis.
    Abraham SJ; Muhamed I; Nolet R; Yeung F; Gaponenko V
    Protein Expr Purif; 2010 Oct; 73(2):125-31. PubMed ID: 20566322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SPRED1 Interferes with K-ras but Not H-ras Membrane Anchorage and Signaling.
    Siljamäki E; Abankwa D
    Mol Cell Biol; 2016 Oct; 36(20):2612-25. PubMed ID: 27503857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation.
    Paz A; Haklai R; Elad-Sfadia G; Ballan E; Kloog Y
    Oncogene; 2001 Nov; 20(51):7486-93. PubMed ID: 11709720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. K-Ras4A splice variant is widely expressed in cancer and uses a hybrid membrane-targeting motif.
    Tsai FD; Lopes MS; Zhou M; Court H; Ponce O; Fiordalisi JJ; Gierut JJ; Cox AD; Haigis KM; Philips MR
    Proc Natl Acad Sci U S A; 2015 Jan; 112(3):779-84. PubMed ID: 25561545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural basis for intramolecular interaction of post-translationally modified H-Ras•GTP prepared by protein ligation.
    Ke H; Matsumoto S; Murashima Y; Taniguchi-Tamura H; Miyamoto R; Yoshikawa Y; Tsuda C; Kumasaka T; Mizohata E; Edamatsu H; Kataoka T
    FEBS Lett; 2017 Aug; 591(16):2470-2481. PubMed ID: 28730604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.